The National Group of Expertise on Pancreatic Cancer Research (KNEP) consists of nine research groups from Oslo, Bergen and Stavanger. Through a joint 5-years project supported by the Norwegian Cancer Society, the groups have bundled their research activities to improve early diagnostics and treatment of pancreatic cancer.
The aim of our project is to stimulate collaboration across disciplines and institutions, and to join experts in the field of pancreatic cancer in order to strengthen research on this disease. The research groups will exchange data and biomaterials so that complex associations between various aspects of pancreatic cancer can be identified at the individual patient level. We seek to achieve much-needed, concrete progress in the management of pancreatic cancer patients. Through its collaborative network, KNEP will establish a competitive and sustainable research environment for pancreatic cancer in Norway.
The consortium comprises the following nine work packages
The research portfolio of KNEP comprises studies in the central clinical fields of
Surgery
Oncology
Medical Genetics
In addition to laboratory studies on:
Multi-omics characterization of tumor tissue
High-throughput drug screening
Histopathology
Metabolomics
Animal models for pancreatic cancer
The research groups are based in Oslo, Bergen, and Stavanger, and collaborate with patients from all over Norway. The University of Oslo is the host institution for this 5-years project.
May 2020 - April 2025
Stay informed about research and activities conducted by KNEP - the Norwegian Cancer Society’s National Group of Expertise on Pancreatic Cancer Research.
The Norwegian Cancer Society’s National Expert Group for Pancreatic Cancer Research (KNEP) hosted the 4th national network meeting on pancreatic cancer research last Friday (March 13th) at the Grand Hotel in Oslo. The event brought together 63 participants from across the country. Program highlights included presentations by Professor Jeff Evans from the University of Glasgow and Kasper Overbeek from the Erasmus MC Cancer Institute Rotterdam. This year's meeting placed a special focus on clinical trials and the surveillance of individuals with a hereditary increased risk of developing pancreatic cancer. The meeting was organized in collaboration with the Pancreatic Cancer Network Norway (PKNN; www.pknn.no), which celebrated its 10th anniversary at the same venue later that day.
The National Network Meeting on Pancreatic Cancer Research will be held on March 13, 2026, at the 'Grand Hotel' in Oslo. The meeting is organized by the Norwegian Cancer Society's National Group of Expertise on Research on Pancreatic Cancer (KNEP; https://knep.no/). The program will include presentations by both international and Norwegian researchers and will conclude with a celebration to mark the 10th anniversary of Pancreatic Cancer Network Norway (PKNN; https://pknn.no). The preliminary program is included below
KNEP researchers from Stavanger University Hospital presented new results last week at the ISMRC (International Symposium on Minimal Residual Cancer) research conference in Nice, France. The results showed a slight improvement in the detection of cancer DNA in blood by using the new methods.
We will get back to you ASAP via email.
